Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01970865
Title	A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	Pfizer
Indications	lung non-small cell carcinoma
Therapies	Lorlatinib Crizotinib
Age Groups:	adult
Covered Countries	USA \| ITA \| FRA \| ESP \| DEU \| CHE \| CAN \| BEL \| AUS